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The crystal structure of Escherichia coli purine nucleoside
phosphorylase: a comparison with the human enzyme reveals a
conserved topology
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Background: Purine nucleoside phosphorylase (PNP) from Escherichia coli
is a hexameric enzyme that catalyzes the reversible phosphorolysis of 6-amino
and 6-oxopurine (2′-deoxy)ribonucleosides to the free base and 
(2′-deoxy)ribose-1-phosphate. In contrast, human and bovine PNPs are
trimeric and accept only 6-oxopurine nucleosides as substrates. The
difference in the specificities of these two enzymes has been utilized in gene
therapy treatments in which certain prodrugs are cleaved by E. coli PNP but
not the human enzyme. The trimeric and hexameric PNPs show no similarity in
amino acid sequence, even though they catalyze the same basic chemical
reaction. Structural comparison of the active sites of mammalian and E. coli
PNPs would provide an improved basis for the design of potential prodrugs
that are specific for E. coli PNP.
Results: The crystal structure of E. coli PNP at 2.0 Å resolution shows that the
overall subunit topology and active-site location within the subunit are similar to
those of the subunits from human PNP and E. coli uridine phosphorylase.
Nevertheless, even though the overall geometry of the E. coli PNP active site is
similar to human PNP, the active-site residues and subunit interactions are
strikingly different. In E. coli PNP, the purine- and ribose-binding sites are
generally hydrophobic, although a histidine residue from an adjacent subunit
probably forms a hydrogen bond with a hydroxyl group of the sugar. The
phosphate-binding site probably consists of two mainchain nitrogen atoms and
three arginine residues. In addition, the active site in hexameric PNP is much
more accessible than in trimeric PNP. 
Conclusions: The structures of human and E. coli PNP define two possible
classes of nucleoside phosphorylase, and help to explain the differences in
specificity and efficiency between trimeric and hexameric PNPs. This structural
data may be useful in designing prodrugs that can be activated by E. coli PNP
but not the human enzyme.
Introduction
Purine nucleoside phosphorylase (PNP) catalyzes the
reversible phosphorolysis of (2′-deoxy)purine ribonucleo-
sides to the free base and (2′-deoxy)ribose-1-phosphate.
The enzyme has been isolated from both eukaryotic and
prokaryotic organisms and functions in the purine salvage
pathway. Sequence analysis among PNPs suggests that
there are two major categories of this enzyme. Mammalian
PNPs, such as those from human erythrocytes and bovine
spleen, are trimeric and have a monomeric molecular weight
of 31 kDa [1–4], whereas prokaryotic PNPs are hexameric
with a monomeric molecular weight of 26 kDa [5–11]. In
general, PNPs with a trimeric structure accept only guano-
sine and inosine as substrates, whereas the hexameric PNPs
accept adenosine as well, although in at least one instance a
hexameric PNP is specific for adenosine and deoxyadeno-
sine [9]. In addition, Escherichia coli PNP is more tolerant of
nucleosides that contain modified ribose moieties, and
compared to mammalian PNP its activity toward purine ara-
binosides is ten times higher [12]. Interestingly, both
trimeric and hexameric PNPs have been observed in Bacil-
lus subtilis [8], E. coli [10] and Bacillus stearothermophilus [11].
The two types of PNPs have different inhibition profiles.
For example, formycin A is completely inactive against
human PNP, but it is a good inhibitor of E. coli PNP
(Ki = 5 µM) [13]. Furthermore, although mammalian PNPs
have higher substrate specificity than the hexameric PNPs,
they are more efficient in the synthesis of 2-oxo-6-substi-
tuted purines and purine analogs than E. coli PNP [14].
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The structure of E. coli PNP is interesting for mechanis-
tic reasons, but it also has practical implications. For
instance, a recently proposed gene therapy for human
tumors takes advantage of the differences in specificity
of human and E. coli PNPs [15]. Certain prodrugs, such
as 2′-deoxy-6-methylpurine, are not cleaved by human
PNP when they are injected into tumor cells. In tumor
cells transfected with the E. coli PNP gene, however, the
nontoxic 2′-deoxy-6-methylpurine is converted by bacte-
rial PNP to the highly cytotoxic base, 6-methylpurine.
The free purine base analog can diffuse freely out of the
cell, thus causing toxicity to the transfected cells as well
as nearby tumor cells. 
We describe here the three-dimensional structure of E. coli
PNP and compare it to the structures of mammalian PNP
and E. coli uridine phosphorylase (UP). All three enzymes
have similar subunit folds, although there is negligible simi-
larity between the amino acid sequences of human and E.
coli PNP and only about 20% identity between UP and E.
coli PNP. All three enzymes have a similar geometric
arrangement of the purine-, ribose- and phosphate-binding
sites, however, E. coli and human PNPs use completely dif-
ferent amino acids within the binding sites. In addition,
although both PNPs utilize residues from adjacent sub-
units, the participating residues are different (His4 and
Arg43 in E. coli PNP and Phe159 in human PNP), owing to
differences in quaternary structure. Finally, the base-
binding site in E. coli PNP is much larger and more accessi-
ble than that of human or bovine PNP.
Results and discussion
Quaternary structure 
E. coli PNP is a disc-shaped hexamer with D3 symmetry as
shown in Figure 1. The hexamer is approximately 60 Å
thick in the direction of the threefold axis and about 100 Å
in diameter. The E. coli PNP hexamer can be viewed as a
trimer of dimers, in which each dimeric pair contains two
complete active sites (Figure 2). The contacts between
subunits within the dimers are more extensive than the
contacts between threefold-related pairs. Two adjacent
subunits are involved in the formation of each active site:
Arg43 from one subunit probably participates in binding
the phosphate via both hydrogen-bonding and electrosta-
tic interactions, and His4 probably forms one or two
hydrogen bonds with the hydroxyl groups of the ribose.
The mutation of Arg43 to lysine destroys PNP activity,
indicating the importance of this subunit contact [16].
In human or calf spleen PNP [1–4], three identical sub-
units form a triangular prism with C3 symmetry that is 45 Å
thick in the direction of the threefold axis and 75 Å along
the sides. In mammalian PNPs, the active site also involves
the participation of two subunits. Although subunit con-
tacts are essential to the formation of the active sites in
both types of PNP, the differences in the surface loops
appear to modulate the quaternary structure. Thus, the
position of subunits in the hexamer with respect to the
symmetry axis is entirely different from the trimer.
Secondary structural features 
E. coli PNP has a central eight-stranded mixed β sheet
with strands labeled β1 to β7 and β9 (β8 is a three-residue
strand that forms several hydrogen bonds with one end of
β7, and β10 is a two-residue strand that forms several
hydrogen bonds with one end of β9; Figures 3 and 4).
Several α helices pack against the core of the β-sheet
structure. Figure 5 shows a sequence alignment according
to a manual superposition of the structures from E. coli
PNP, human PNP and E. coli UP. E. coli PNP shows no
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Figure 1
Stereo view of the E. coli PNP hexamer
viewed down the noncrystallographic
threefold axis. Models of inosine and
phosphate (red) are shown in the proposed
active sites. (The models of inosine and
phosphate included in Figures 1–4, 6 and 7
are based on a comparison with structures of
human PNP with bound substrates.) The
subunits related by the threefold axis have the
same color. The subunits in each green and
blue dimeric pair are related to each other by
horizontal noncrystallographic twofold axes.
(The figure was made using the program
CHAIN [39].)
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apparent sequence similarity to human PNP, but it shows
about 20% identity with UP [17], which is also hexameric
[18,19]. The similarity of the overall topology of the α
helices and the β sheet in the structures of both PNPs and
UP is illustrated in Figure 6. As expected, E. coli PNP and
UP show structural homology. In addition, even though
the sequences of E. coli and human PNP show little simi-
larity, the secondary structures also correlate quite well
with each other. All three structures have a central eight-
stranded mixed β sheet, as well as a three-residue strand
(β8) that forms several hydrogen bonds with one end of
β7. In each molecule, the C-terminal helix is the longest
helix. None of the enzymes contain the classical βαβαβ
topology characteristic of the Rossmann fold [20], even
though they have both phosphate- and nucleoside-binding
sites. Many of the residues in the active site are close to
the middle four strands in the eight-stranded β sheet.
These four strands are parallel to each other with their C-
terminal ends pointing towards the active site. In E. coli
PNP and UP, the central β sheets are flanked by seven α
helices, while human PNP has one additional helix near
the N terminus (α0 in Figure 5). Neither human PNP or
UP have a short β strand corresponding to β10 in E. coli
PNP. Superposition of the three structures based on the
Cα positions of the 64 residues in the nine common β
strands gives root mean square (rms) differences of 1.3 Å
for human PNP, 1.3 Å for bovine PNP and 1.0 Å for UP.
Including the five common α helices in the superposition
(a total of 133 residues) gives rms differences of 2.0 Å for
human PNP, 2.1 Å for bovine PNP and 1.3 Å for UP.
In E. coli PNP, the β-strand content is about 27%, com-
pared with 23% in human PNP, and the α-helical content
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Figure 3
The overall fold of the E. coli PNP subunit. The β strands (green) and α
helices (blue) are labeled. Models of inosine and phosphate (red) are
shown in the proposed active sites. (The figure was made using the
program RIBBONS [40].)
Figure 2
Stereo view of two E. coli PNP subunits with
bound substrate viewed down the
noncrystallographic twofold axis. Models of
inosine and phosphate (red) are shown in the
proposed active sites; the N and C termini are
marked. (The figure was made using the
program CHAIN [39].)
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is 34% versus 33% in human PNP. Overall, E. coli PNP
has 5% more secondary structure than human PNP, even
though the E. coli subunit has only 238 amino acids com-
pared to 289 in the human PNP subunit. Human PNP has
proportionally more loops and turns. As expected, many of
these turns and loops are involved in subunit–subunit con-
tacts or contribute to active sites. In other words, the
similar β-sheet and α-helical arrangement of these two
enzymes has little effect on the details of the active sites.
Instead, the variation in active sites comes from the differ-
ences in loops and turns. While the core of the secondary
structure remains more or less constant, the loops show
one of two patterns, depending on the quaternary struc-
ture. In the case of the hexameric enzymes, the loops are
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Figure 4
Stereo view of a Cα tracing of the E. coli PNP
monomer with every twentieth residue labeled.
Models of inosine and phosphate are shown
in red. (The figure was made using the
program CHAIN [39].)
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Figure 5
Sequence alignment of E. coli PNP (EPNP),
human PNP (HPNP) and E. coli uridine
phosphorylase (UP) based on a superposition
of the corresponding α helices and β strands.
Symbols α and β represent the secondary
structure elements for the three proteins. The
helix α0 is present only in human PNP, α3 is
not present in human PNP, and β10 is
present only in E. coli PNP. Gaps introduced
into the sequences for the purpose of
alignment are represented by the dotted
regions.
	            α0             β1       α1          β2
EPNP             ATPHINAEMGDFADVVLMPGDPLRAKYIAETFLEDAREVNNVRGML....  46
HPNP MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGS...GLGGLTDKLTQAQIFDYSEIPNFPRS  59
UP         MSKSDVFHLGLTKNDLQGATLAIVPGDPDRVEKIAALM.DKPVKLASHREFT....  51


               β3     β4                    α2             β5
EPNP ........GFTGTYKGRKISVMGHGMG......IPSCSIYTKELITDFGVKKIIRVGSCGAV  94
HPNP TVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLL.GVDTLVVTNAAGGL 120
UP   ........TWRAELDGKPVIVCSTGIG......GPSTSIALEELAQL.GIRTFLRIGTTGAI  98


                 β6       α3                              α4 
EPNP LPHVKLRDVVIGMGACTDSKVNRIRFKDHDFAAIAD...........FDMVRNAVDAAKALG 145
HPNP NPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMG 182
UP   QPHINVGDVLVTTASVRLDGASLHFAPLEFPAVAD............FECTTALVEAAKSIG 148


            β7                              α5      β8       α6 
EPNP ID..ARVGNLFSADLFYSPDGE..............MFDVMEKYGILGVEMEAAGIYGVAAE 191
HPNP EQRELQEGTYVMVAGPSFETVA..............ECRVLQKLGADAVGMSTVPEVIVARH 230
UP   AT..THVGVTASSDTFYPGQERYDTYSGRVVRHFKGSMEEWQAMGVMNYEMESATLLTMCAS 208


            β9        β10                   α7
EPNP FGKALTICTVSDHIRTHEQTT........AAERQTTFNDMIKIALESVLLGDKE         238
HPNP CGLRVFGFSLITNKVIMDYESLEKANHEEVLA AGKQAAQKLEQFVSILMASIPLPDKAS   289
UP   QGLRAGMVAGVIVNRTQQEIPN........AETMKQTESHAVKIVVEAARRLL          253
Structure
generally of similar length, while in trimeric mammalian
PNP the loops are significantly different.
Subunit contacts
The residues of E. coli PNP involved in interface contacts
are 3–4, 20–23, 42–43, 64–65, 67–68, 71–72, 158–160, 162,
180, and one side of helix 112–119. The nature of these
interactions is mainly hydrophobic, although a few hydro-
gen bonds mediate polar–polar interactions. The active
sites of adjacent subunits are separated by a pair of loops:
Gly63-Met64-Gly65-Ile66-Pro67-Ser68 and Ile71-Tyr72.
The first is a glycine-rich turn from the β4 strand to the
α2 helix and passes near the phosphate-binding site.
Although the loop is not directly involved in phosphate
binding, it is conserved between E. coli PNP and UP
[18,19]. On the other hand, E. coli PNP and UP do differ
in the nature of a turn (β2–β3) which bridges each pair of
twofold related phosphate-binding sites: Val42-Arg43 in
E. coli PNP and His47-Arg48 in UP. Arg43 in E. coli PNP
is able to extend into the phosphate-binding site of the
other subunit, whereas the sidechain of Arg48 in UP is
disordered and not defined in the crystal structure.
The active site 
Complexes of E. coli PNP with sulfate, ribose-1-phos-
phate, and 6-iodopurine have been examined by differ-
ence Fourier methods. Although electron density for each
of these small molecules was apparent in the difference
maps, in each case the electron density was weak and
poorly defined so accurate placement of the substrates was
impossible. Comparison of these structures with human
PNP, bovine PNP and E. coli UP, however, has allowed
the development of a model for all substrate-binding posi-
tions. If the subunits of trimeric PNP, hexameric PNP and
UP are superimposed by aligning the secondary structure
elements, then the purine- (or pyrimidine in the case of
UP), ribose- and phosphate- binding sites also superim-
pose (Figure 6). The most conserved feature is the sec-
ondary structure near the substrate. The residues in E. coli
PNP that are probably involved in substrate binding are
listed in Table 1 and shown in Figure 7a; for comparison,
the residues in human PNP that are involved in substrate
binding are also given. In each active site, part of the β5
strand stretches from the phosphate-binding site to the
base-binding site. The portion of β5 involved includes
residues 90–93 (Ser–Cys–Gly–Ala) for E. coli PNP,
116–119 (Ala–Ala–Gly–Gly) for human PNP, and 94–97
(Thr–Thr–Gly–Ala) for UP. Interestingly, this subtle
structural homology was detected prior to the structure
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Table 1
Residues in the active sites of E. coli and human PNP.
E. coli PNP Human PNP
Phosphate Gly20 Ser33
Arg24 Arg84
Arg87 His86
Ser90 Ala116
Arg43* Ser220
Base Ser90 Ala116
Cys91 Ala117
Gly92 Gly118
Phe159 Phe200
Phe167 Glu201
Val178 Val217
Glu179 Gly218
Met180 Met219
Asp204 Asn243
Ile206 Lys244
Phe159*
Ribose Met64 His86
Phe159 Tyr88
Val178 Phe200
Glu179 Val217
Met180 Gly218
His4* Met219
His257
Phe159*
*The residue is contributed by an adjacent subunit. 
Figure 6
Superimposed structures of E. coli PNP (green), human PNP (blue)
and E. coli UP (orange). The orientation is the same as in Figure 3. The
superposition is based on 64 residues in the nine common β strands
of each structure. Models of inosine and phosphate are shown in red.
(The figure was made using the program RIBBONS [40].)
determination, by Mushegian and Koonin using computer
assisted sequence analysis [21].
The relationship between the neighboring active sites is
completely different in hexameric E. coli PNP and trimeric
mammalian PNP. In the E. coli PNP hexamer, the dis-
tance between the closest phosphate centers is about
22 Å, which is much shorter than the value of 35 Å for
trimeric PNP [1–4]. The active sites in the mammalian
PNP are situated near the equator of the trimer. In con-
trast, when E. coli PNP is viewed down the threefold
axis, three active sites are located on top of the molecule
and the other three, related by the twofold axis, lie on
the bottom of the molecule. The closest pairs of phos-
phate sites are related by the twofold axes. It is possible
that communication between the phosphate sites in each
pair is responsible for the strong negative cooperativity
observed for E. coli PNP [5].
Phosphate-binding site
According to our model, the phosphate-binding site of 
E. coli PNP includes Arg24 and Arg87 from one subunit
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Figure 7
Stereo view of the active sites in E. coli and
mammalian PNPs. (a) In the proposed active
site of E. coli PNP, fourteen of the sixteen
residues are from one subunit (green), and
two (His4 and Arg43) are from an adjacent
subunit (blue). Models of inosine and phos-
phate are shown in red. (b) In the active site
of human PNP with bound phosphate and
guanine (PDB entry code 1ULB), sixteen of
the seventeen residues are from one subunit
(green), and one (Phe159) is from the adja-
cent subunit (blue). Guanine and phosphate
are shown in red. (The figure was made using
the program CHAIN [39].)
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and Arg43 from a neighboring subunit (the corresponding
residues in human PNP are Arg84, His86 and Ser220); all
of these residues form sidechain interactions with the
phosphate oxygen atoms (Table 1; Figure 7). In E. coli
PNP, both sidechain and backbone atoms from Ser90 also
contribute to phosphate binding forming hydrogen bonds
with the phosphate ion. In addition, an arginine residue at
the beginning of helix α7, Arg217, approaches the phos-
phate-binding site, but the guanido group is probably at
least 8 Å from the closest phosphate oxygen.
Although different residues are used by mammalian and
E. coli PNPs for phosphate binding, several similarities
exist. Both phosphate-binding sites are located in the
same region relative to the secondary structure elements
and probably use residues from the β1−α1 turn. In mam-
malian PNP two hydrogen bonds are formed with the
phosphate anion by mainchain nitrogen atoms in the β5
strand (Ala116) and the β1−α1 turn (Ser33); in E. coli PNP
the corresponding residues are Gly20 and Ser90. Similarly,
in mammalian PNP one oxygen of the phosphate anion
forms a hydrogen bond to a water molecule associated
with the carbonyl oxygen of Ala116 in the β5 strand; the
carbonyl oxygen of Ser90 in E. coli PNP is positioned such
that a similar interaction could occur if the phosphate
oxygen is protonated. The Ser90 sidechain interaction,
however, has no counterpart in mammalian PNP.
Even though there is no typical phosphate-binding site
when compared to other phosphate-binding proteins [22],
E. coli and mammalian PNPs belong to the group of phos-
phate-binding proteins in which phosphates are found in
close proximity to the N terminus of an α helix (α1). Both
PNPs utilize the most commonly found residues at phos-
phate binding sites, which are glycine, arginine, threonine
and serine. Because of the presence of histidine residues,
the phosphate-binding site in mammalian PNP is unique
when compared to phosphate-binding sites that utilize
helix-type dipoles [22].
Base-binding site
The base-binding site in E. coli PNP appears to consist
primarily of hydrophobic residues (Table 1; Figure 7).
Three of the hydrophobic residues utilized in E. coli PNP
(Val178, Met180 and Phe159) correspond to residues
Val217, Met219 and Phe159 (from an adjacent subunit) in
human PNP. However, two other hydrophobic residues
in the E. coli PNP base-binding site (Phe167 and Ile206)
do not have counterparts in the human PNP active site.
Instead, the corresponding residues are hydrophilic (Glu201
and Lys244), and they contribute hydrogen bonds to N1,
the amino group at the C3 position, and the carbonyl
oxygen at the C6 position of the base. The mainchain
atoms of residues 90–92 (within the β5 strand) in E. coli
PNP also form part of the base-binding pocket. In human
PNP similar interactions are provided by residues 116–118,
which are also part of the β5 strand. There are two addi-
tional hydrophobic residues in the base-binding pocket
of E. coli PNP (Phe167 and Ile206) and one in human
PNP (Phe200) which have no counterparts in the other
structure. Asp204 of E. coli PNP, which corresponds to
Asn243 in human PNP and Asn222 in UP, is located near
N7 of the purine base and may be important for catalysis.
The arrangement of the active-site residues is illustrated
in Figure 7.
This base-binding pocket of E. coli PNP differs from
bovine or human PNP in several significant respects.
Firstly, the strong complementary hydrogen-bonding
pattern provided by Glu201 (in the β7–α5 loop) and
Asn243 (in the β9 strand) of mammalian PNP (and
similar residues in other purine base binding proteins
such as adenosine deaminase and GTP-binding protein
[23]) is not found in the E. coli enzyme. The β7–α5 loop
in E. coli PNP has swung away from the base-binding
site by about 7–8 Å relative to mammalian PNP. Asn243
in the β9 strand of mammalian PNP probably forms
hydrogen bonds with N7 of the purine base and OG1 of
Thr242. The corresponding residue in E. coli PNP
(Asp204) would have to be protonated in order to provide
similar interactions with N7 and OG of Ser203. Secondly,
the base-binding and nucleoside-binding sites are remark-
ably more open in E. coli PNP, as compared with bovine
or human PNP. This observation may explain the much
broader specificity of the E. coli enzyme and the higher
efficiency of the mammalian enzyme. Finally, in mam-
malian PNP residues 257–261 (part of the large disor-
dered β9–α7 loop consisting of residues 241–260) is
transformed into an ordered α helix upon base or nucleo-
side binding, and this conformational change closes the
sugar-binding site. This change is not likely to occur in
E. coli PNP, because the corresponding loop is eight
residues shorter and is well ordered in the purine-free
native structure.
Ribose-binding site
The proposed mechanism of ribose-binding in E. coli PNP
is similar to that described for mammalian PNP, in that
both enzymes primarily use hydrophobic van der Waals
contacts (Table 1; Figure 7). The β8–α6 region (shown in
Figures 3 and 4), consists of residues Val178-Glu179-
Met180 (E. coli PNP) and Val217-Gly218-Met219 (human
PNP); the methionine residue lies across the hydrophobic
face of the ribosyl group and has been identified in all
known PNP sequences.
In human or bovine PNP, Phe159 (located on a loop 
from an adjacent subunit) participates in the active site
by completing a hydrophobic patch near the ribosyl
group. In E. coli PNP, the absence of such a loop and 
the different subunit arrangement alter this interaction
feature. However, Phe159 in the E. coli enzyme, which
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coincidentally has the same residue number, occupies the
same relative position in the ribose-binding site as Phe159
from the adjacent subunit in mammalian PNP.
As noted above, binding of the substrate causes move-
ment of a large loop (residues 241–260) in mammalian
PNPs. The maximum movement occurs at His257, which
is displaced outwards by 5–6 Å in human PNP and 2–3 Å
in bovine PNP, and it allows the formation of a hydrogen
bond with the O5′ hydroxyl group of the ribose. This loop
is not present in E. coli PNP, but His4 in an adjacent
subunit occupies a similar position in the ribose-binding
pocket and would probably be able to form a hydrogen
bond to the O3′ hydroxyl group of the ribose.
Mechanism of catalysis
The available structural information from E. coli PNP
complexed with sulfate and ribose-1-phosphate indicates
that the phosphate-binding site is similar for both reac-
tant and product. In studies of bovine PNP (CM et al.,
unpublished data) a ribosyl group was found binding the
enzyme in only two situations: as part of the nucleoside
(with or without phosphate) or as part of ribose-1-phos-
phate only in the presence of purine base. In the mam-
malian enzyme, ribose-1-phosphate binding is probably
facilitated by a purine-induced conformational change
that brings His257 into position to form a hydrogen bond
with O5′ of the ribose. In E. coli PNP, however, no evi-
dence exists for a loop→helix transition or other signifi-
cant conformational changes. Furthermore, the E. coli PNP
complex with ribose-1-phosphate could be prepared in
the absence of a purine base. Binding of either purine
base or ribose-1-phosphate alone is consistent with a
random bi-bi mechanism in the synthetic direction, as has
been proposed from inhibition studies [24,25].
The negatively charged nature of the phosphate has a great
impact on the catalytic mechanism in both mammalian and
E. coli PNPs. In both cases positively charged residues are
spread on one hemisphere of the phosphate-binding site,
away from the ribose and base-binding sites and interact
with the phosphate. The opposite side of the phosphate is
left exposed to the rest of the active site. This exposed side
of the phosphate ion will certainly alter the electrostatic
properties of the nucleoside after binding. In mammalian
PNPs, there are six to eight hydrogen bonds between the
phosphate oxygen atoms and the protein or water mol-
ecules. Although the binding site is not as clear in E. coli
PNP, three of the four phosphate oxygen atoms probably
form a total of at least five hydrogen bonds with Gly20 N,
Arg24 NH2, Ser90 N, Ser90 OG and Arg87 NH1, while the
oxygen atom that forms a bond with the ribosyl C1′ has no
obvious hydrogen-bond donors or acceptors. The strong
interactions around the phosphate ion in each case suggest
that the ribosyl group rather than the phosphate ion moves
during the chemical reaction.
Bovine PNP hydrolyzes nucleoside with about 100-fold
lower efficiency compared with phosphorolysis [26].
Inosine hydrolysis in mammalian PNP is thought to occur
when His64 swings away from the active site, thus expos-
ing the ribosyl group [2]. In comparison the phosphate
binding site in E. coli PNP appears to be rigid with Arg43
of the neighboring subunit occupying the closed position
of His64. This observation suggests that the ribosyl group
will not be easily accessible by solvent and therefore
resistant to hydrolysis. To date, no reports of nucleoside
hydrolysis by E. coli PNP have appeared in the literature.
Biological implications
Purine nucleoside phosphorylase (PNP) from E. coli is
a hexameric enzyme that catalyzes the reversible phos-
phorolysis of 6-amino and 6-oxopurine (2′-deoxy)ribo-
nucleosides to the free base and (2′-deoxy)ribose-1-
phosphate. In contrast, mammalian (e.g. human and
bovine) PNPs are trimeric and accept only 6-oxopurine
nucleosides as substrates. 
Sequence alignment between human PNP and E. coli
PNP shows little similarity with only 11% apparent
sequence identity [27]. Nevertheless, even though the
quaternary structures of the enzymes differ and there is
no obvious sequence similarity, this study has shown that
both E. coli and mammalian PNPs have the same subunit
topology. Furthermore, both enzymes catalyze the same
reaction, even though there are differences in the amino
acids within the active site as well as differences in sub-
strate specificity. The fact that the chemical reaction type
and topology are conserved, while quaternary structure,
specificity and reaction mechanism vary between trimeric
and hexameric PNPs, is truly remarkable.
It has been shown that all available sequence data for
PNPs show similarity to either human PNP or E. coli
PNP. Consequently, the structures of these two enzymes
define two possible classes that probably encompass most
PNPs. Furthermore, the crystal structure of E. coli PNP
described here reveals similar subunit topology and a
similar active-site location with E. coli uridine phosphory-
lase, which catalyzes a different reaction.
The structural data reported here may have important
implications in the design of prodrugs for use in gene
therapy. For example, E. coli PNP (but not human PNP)
is capable of catalyzing the conversion of several non-
toxic deoxyadenosine analogs to highly toxic adenine
analogs. Recently, Sorscher et al. [15] utilized this differ-
ence in specificity to study tumor cell killing in vitro by
cells transfected with the E. coli PNP gene. In their study,
the expression of E. coli PNP in <1% of the cells in a
human colonic carcinoma cell line led to the death of vir-
tually all bystander cells after treatment with 6-methyl-
purine-2′-deoxyribonucleoside, a deoxyadenosine analog
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that is a substrate for E. coli PNP but not human PNP.
Furthermore, the E. coli PNP structure may suggest
mutant PNP enzymes with more effective activation
properties. Such studies may eventually lead to devel-
opment of a toxin-mediated gene therapy for human
malignancy.
Materials and methods
Crystallization and data collection
Purified protein was provided by Wellcome Research Laboratories. Crys-
tals of the native protein were grown by the hanging-drop method in
12–14% PEG 4000 with 50 mM citrate buffer (pH 4.8–5.0). With the
help of micro seeding techniques, crystals as large as 0.6 × 0.6 × 0.4 mm
were obtained after one week. The crystals are tetragonal rods with
space group P21 and unit cell constants a = 89.5 Å, b = 111.5 Å,
c = 74.8 Å and β = 110.7°. There is one hexamer per asymmetric unit.
Based on a molecular weight of 155,712 Da, as predicted from the
cDNA, the value of Vm [28] is 2.24, which corresponds to a solvent
volume fraction of 45%.
Prior to data collection the crystals were kept in a stabilizing mother
liquor that contained 20–25% PEG 4000. Data were collected at room
temperature with a San Diego Multiwire Area Detector using CuKα radia-
tion from a Rigaku RU-200 rotating-anode generator operating at 40 kV
and 100 mA. The twin detectors were set at distances of 500 mm and
560 mm with two-theta angles asymmetrically offset by 30° and 23° from
the center. Native crystals diffracted beyond 2.0 Å resolution. Potential
heavy-atom derivatives were prepared by soaking native PNP crystals in
a stabilizing solution containing the heavy atom at a concentration of
1 mM or saturated, whichever was less. Potential substrate–inhibitor
complexes were prepared in a similar manner. All soaks were for 24 h. Of
a dozen possible heavy-atom derivatives that were analyzed, only 6-
iodopurine and K2PtCl6 were useful. Table 2 contains a summary of the
data collection statistics for the native and heavy-atom derivative crystals.
Initial determination of phases
Calculation of a self-rotation function using the program AMORE [29]
demonstrated a noncrystallographic threefold axis and three twofold
peaks perpendicular to the threefold axis. These results were consis-
tent with a hexameric structure with D3 symmetry. As UP from E. coli
has a hexameric structure with the same symmetry and about 20%
sequence identity with E. coli PNP, it seemed likely that it would serve
as a molecular replacement (MR) model. A translation search on the x
and z axes was performed using AMORE and XPLOR [30] and data in
the resolution range 15.0 Å – 6 Å. The UP hexamer was used as the
search model, after all sidechains were truncated after the Cβ atom.
The correct position of the model corresponded to the highest peak in
the list of possible solutions (correlation coefficient of 37% and R
factor of 50%). The R factor of the MR model increased to a random
value around 6.5 Å resolution, so the model phases were only useful at
resolutions lower than 6.5 Å. Subsequent analysis with the SIGMAA
program [31] gave similar results.
Using the initial phases provided by the UP polyalanine model, differ-
ence Fourier analyses were employed on the potential heavy-atom
derivatives. For the 6-iodopurine and K2PtCl6 derivatives, the top six
peaks in difference Fourier maps calculated at 6 Å resolution indicated
the same position on each subunit. The heavy-atom positions were
refined using the PHASES program [32] and then used to generate the
first set of MIR phases, which was very poor even at 6.0 Å. After map
modification by symmetry-averaging, however, the protein-solvent
boundary was clearly distinguishable. 
Phase improvement and phase extension
Because of the poor low-resolution phases and the lack of useful phase
information beyond 6.0 Å, a special phase extension procedure was
used. Beginning at 6.0 Å resolution the phases were extended to 2.5 Å
using symmetry-averaging and solvent-leveling, which led to high-resolu-
tion maps for model building. The density modification was performed on
2Fo–Fc maps instead of Fo maps. In the later stages, a (2mFo–DFc) map
weighted by SIGMAA [32] was used for symmetry-averaging when
partial models became available. Calculations were performed using the
CCP4 package [33] and the RAVE program suite [34,35].
The noncrystallographic symmetry (NCS) matrices were calculated
from the self-rotation search result, and the center of the symmetry axis
was calculated from the six heavy atom peak positions and confirmed
by the UP model. A mask in the P21 space group was generated by
using the UP polyalanine model with a 3.5 Å radius from the center of
each atom. Electron densities were set to zero outside the mask, while
inside the mask the densities were replaced by their averaged values
from the six symmetry-related regions. Using the molecular isomor-
phous replacement (MIR) map calculated from 6-iodopurine and
K2PtCl6 derivatives at 6 Å resolution, an extension from 6 to 3 Å resolu-
tion was performed in 26 steps. Each phase extension step included a
new resolution bin which was calculated based on equally dividing the
reciprocal D spacing in the resolution range from 6.0 to 3.0 Å, so that a
roughly equal number of reflections was included in each step. The R
factor and correlation coefficient were 0.30 and 0.65, respectively,
after the extension. Although the phases were calculated to 3 Å resolu-
tion, the best map was at 4 Å resolution.
Model building as part of the phase extension procedure
The resulting 4 Å map showed traceable electron densities. The contin-
uous β strands were resolved, α helices were clearly visible, and some
large sidechains could be seen. Based on this map, continuous Cα
models were easily built from the N terminus to the C terminus for each
subunit. Even though some connections in loop regions were not clear,
most of the chain direction was defined with confidence. Immediately
after building this model, the function lego in the program O was used
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Table 2
Summary of data collection for the native crystals and heavy-atom derivatives. 
Data set Resolution Total Unique Completeness Rsym† < I/σ>
(Å) observations reflections* (%)
Native‡ 2.0 230,200 70,600 70 8.7 5.3
6-Iodopurine 2.2 241,169 55,185 84 11.7 5.2
K2PtCl6 2.2 211,058 52,310 79 15.0 4.0
*The number of unique reflections is based on F > 2σ. 
†Rsym = ΣΣI– Ii/ΣI, where I is the mean intensity of the N reflections
with intensities Ii and common indices h,k,l. ‡The native data were
collected on a crystal in a mother liquor containing sodium tungstate in
an attempt to make a tungstate derivative. When it became apparent that
there was no tungstate in the derivative, the data were treated as native.
The completeness of the native data is about 90% in the 2.6 Å resolution
bin, but drops to only 67% in the 2.0 Å resolution bin.
to complete the backbone from the Cα positions [36]. Cβ carbons
were assigned to every Cα carbon, and many major fitting errors were
corrected by visual inspection. At this stage, the number of protein
atoms included in the model was about half of the total in the molecule.
After one round of positional refinement of this polyalanine model in
XPLOR, the R factor dropped to 44%. The partial model from posi-
tional refinement was used to calculate a map at 5.0 Å resolution, and
the initial MIR phases were abandoned. The phase extension through
density modification was applied again for the new map in the resolu-
tion range from 5.0 Å to 3.0 Å. This 3 Å map showed many well
defined sidechains. The first 100 residues were fit smoothly, but the
middle portion of the polypeptide chain was ambiguous. At this point,
having developed confidence in this procedure, the phase improve-
ment and extension procedures were repeatedly used with the updated
models to get better maps. Model building was carried out conserva-
tively to avoid adding incorrect information, and the protein-solvent
mask and NCS matrices were slowly improved during extension to
higher resolution. This process led to a steady improvement in the map
until the nearly complete sequence was visible. 
Refinement
The refinement of E. coli PNP in space group P21 required careful
treatment of each individual subunit. The complete molecule contains
six subunits with a total of 1422 residues in one asymmetric unit. One
might expect that some of the residues in each subunit would be differ-
ent, especially at high resolution, as a result of different crystallographic
environments. Therefore, a mixture of several methods was employed in
the refinement. Initially, positional and simulated-annealing refinement
was performed on the model, and the averaged difference maps
(2Fo–Fc and Fo–Fc) were calculated as references for model adjust-
ment. Using the updated refined models and NCS, the phase extension
cycles were started at a higher resolution. Better maps were generated
in this back and forth manner.
Refinement of the complete model of E. coli PNP was begun with strict
NCS constraints at 3.0 Å resolution, but after initial refinement the con-
straints were dropped. After adjusting the model according to the aver-
aged Fo–Fc and 2Fo–Fc maps, the model was refined against the native
data at 2.0 Å resolution. The R factor at this point was 26%, and the free
R factor was 34%. Analysis by PROCHECK [37] indicated that about
10% of the total residues needed to be adjusted. From the refined coor-
dinates of six subunits, NCS matrices were recalculated. The Cα rms
deviations were invariably around 0.5 Å, and a deviation of 0.5° from a
strict twofold or threefold was found in the subunit–subunit relationship.
The R factor distribution showed that the R factor increased around 3 to
3.5 Å. Thus, the model coordinates were used to calculate a map at
3.5 Å, and the map was subjected to phase improvement and phase
extension from 3.5 Å to 2.5 Å. After refitting of the model using this map,
the model was refined using the data to 2.0 Å resolution. Although group
B factors were used at lower resolution (3.0 Å), analysis of the free R
factor at high resolution indicated that individual B factors gave a better
refinement, so individual B factors were included in the final refinement.
Water molecules were added automatically by a series of small programs
written to search the peaks in the Fo–Fc map and check distance criteria
for reasonable hydrogen-bond donors and acceptors. After refinement,
only water molecules with a B factor less than 40 Å2 and occupancy
larger than 50% were included. 
The final model includes 1422 residues (237 residues out of a reported
238 per subunit [38]) and 480 water molecules. The C-terminal residue
in each subunit (Glu238) was not present in the electron-density maps.
The R factor is 20%, and the free R factor is 29%; the free R factor is
only 25% at 3.0 Å resolution. Table 3 lists the refinement statistics. The
rms deviations between subunits for Cα atoms range from 0.3 to 0.4 Å
with the largest differences occurring in the loop that includes residues
210–216.  This loop is on the surface of the molecule and is not involved
in any intramolecular contacts, nor does it appear to function in the active
site. A Ramachandran plot showed that 88.3% of the residues were
located in most favored regions (range 87.4% to 90.3% for the six sub-
units), and only two residues (0.2%) were in generously allowed regions;
none were in disallowed regions (Table 3).
Accession numbers
The atomic coordinates of the refined structure have been deposited
with the Brookhaven Protein Data Bank (entry number 1ECP).
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